_version_ 1784623963536621568
author Lázaro-Navarro, Juan
Pimentel-Gutiérrez, Helia Judith
Gauert, Anton
Hagemann, Anja I. H.
Eisenschmid, Jassi
Gökbuget, Nicola
Vick, Binje
Jeremias, Irmela
Seyfried, Felix
Meyer, Lüder Hinrich
Debatin, Klaus-Michael
Richer, Kathrin
Bultman, Miriam
Neumann, Martin
Hänzelmann, Sonja
Serve, Hubert
Astrahantseff, Kathy
Rieger, Michael A.
Eckert, Cornelia
Baldus, Claudia D.
Bastian, Lorenz
author_facet Lázaro-Navarro, Juan
Pimentel-Gutiérrez, Helia Judith
Gauert, Anton
Hagemann, Anja I. H.
Eisenschmid, Jassi
Gökbuget, Nicola
Vick, Binje
Jeremias, Irmela
Seyfried, Felix
Meyer, Lüder Hinrich
Debatin, Klaus-Michael
Richer, Kathrin
Bultman, Miriam
Neumann, Martin
Hänzelmann, Sonja
Serve, Hubert
Astrahantseff, Kathy
Rieger, Michael A.
Eckert, Cornelia
Baldus, Claudia D.
Bastian, Lorenz
author_sort Lázaro-Navarro, Juan
collection PubMed
description
format Online
Article
Text
id pubmed-8714730
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-87147302021-12-29 Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation Lázaro-Navarro, Juan Pimentel-Gutiérrez, Helia Judith Gauert, Anton Hagemann, Anja I. H. Eisenschmid, Jassi Gökbuget, Nicola Vick, Binje Jeremias, Irmela Seyfried, Felix Meyer, Lüder Hinrich Debatin, Klaus-Michael Richer, Kathrin Bultman, Miriam Neumann, Martin Hänzelmann, Sonja Serve, Hubert Astrahantseff, Kathy Rieger, Michael A. Eckert, Cornelia Baldus, Claudia D. Bastian, Lorenz Blood Adv Research Letter American Society of Hematology 2021-12-17 /pmc/articles/PMC8714730/ /pubmed/34610112 http://dx.doi.org/10.1182/bloodadvances.2021004513 Text en © 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Research Letter
Lázaro-Navarro, Juan
Pimentel-Gutiérrez, Helia Judith
Gauert, Anton
Hagemann, Anja I. H.
Eisenschmid, Jassi
Gökbuget, Nicola
Vick, Binje
Jeremias, Irmela
Seyfried, Felix
Meyer, Lüder Hinrich
Debatin, Klaus-Michael
Richer, Kathrin
Bultman, Miriam
Neumann, Martin
Hänzelmann, Sonja
Serve, Hubert
Astrahantseff, Kathy
Rieger, Michael A.
Eckert, Cornelia
Baldus, Claudia D.
Bastian, Lorenz
Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
title Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
title_full Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
title_fullStr Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
title_full_unstemmed Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
title_short Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
title_sort inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via mcl1 degradation
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714730/
https://www.ncbi.nlm.nih.gov/pubmed/34610112
http://dx.doi.org/10.1182/bloodadvances.2021004513
work_keys_str_mv AT lazaronavarrojuan inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT pimentelgutierrezheliajudith inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT gauertanton inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT hagemannanjaih inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT eisenschmidjassi inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT gokbugetnicola inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT vickbinje inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT jeremiasirmela inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT seyfriedfelix inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT meyerluderhinrich inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT debatinklausmichael inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT richerkathrin inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT bultmanmiriam inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT neumannmartin inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT hanzelmannsonja inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT servehubert inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT astrahantseffkathy inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT riegermichaela inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT eckertcornelia inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT baldusclaudiad inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation
AT bastianlorenz inhibitingcaseinkinase2sensitizesacutelymphoblasticleukemiacellstovenetoclaxviamcl1degradation